• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮受体信号转导的结构和分子决定因素。

Structural and molecular determinants of mineralocorticoid receptor signalling.

机构信息

Julius Bernstein Institute of Physiology, Martin Luther University Halle-Wittenberg, Halle, Saale, Germany.

Departamento de Ciencias Médicas Básicas and Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Tenerife, Spain.

出版信息

Br J Pharmacol. 2022 Jul;179(13):3103-3118. doi: 10.1111/bph.15746. Epub 2021 Dec 12.

DOI:10.1111/bph.15746
PMID:34811739
Abstract

During the past decades, the mineralocorticoid receptor (MR) has evolved from a much-overlooked member of the steroid hormone receptor family to an important player, not only in volume and electrolyte homeostasis but also in pathological changes occurring in an increasing number of tissues, especially the renal and cardiovascular systems. Simultaneously, a wealth of information about the structure, interaction partners and chromatin requirements for genomic signalling of steroid hormone receptors became available. However, much of the information for the MR has been deduced from studies of other family members and there is still a lack of knowledge about MR-specific features in ligand binding, chromatin remodelling, co-factor interactions and general MR specificity-conferring mechanisms that can completely explain the differences in pathophysiological function between MR and its closest relative, the glucocorticoid receptor. This review aims to give an overview of the current knowledge of MR structure, signalling and co-factors modulating its activity. LINKED ARTICLES: This article is part of a themed issue on Emerging Fields for Therapeutic Targeting of the Aldosterone-Mineralocorticoid Receptor Signaling Pathway. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.13/issuetoc.

摘要

在过去的几十年里,盐皮质激素受体(MR)已经从类固醇激素受体家族中一个被忽视的成员发展成为一个重要的角色,不仅在体积和电解质平衡中发挥作用,而且在越来越多的组织中发生的病理变化中发挥作用,特别是在肾脏和心血管系统中。同时,关于类固醇激素受体基因组信号转导的结构、相互作用伙伴和染色质要求的大量信息也已经可用。然而,关于 MR 的信息大部分是从其他家族成员的研究中推断出来的,对于配体结合、染色质重塑、共因子相互作用以及一般的 MR 特异性赋予机制中的 MR 特异性特征仍然缺乏了解,这些机制可以完全解释 MR 和其最接近的亲属糖皮质激素受体在病理生理学功能上的差异。这篇综述旨在概述 MR 结构、信号转导以及调节其活性的共因子的最新知识。相关文章:本文是关于醛固酮-盐皮质激素受体信号通路的治疗靶点新兴领域的专题的一部分。要查看本节中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.13/issuetoc.

相似文献

1
Structural and molecular determinants of mineralocorticoid receptor signalling.醛固酮受体信号转导的结构和分子决定因素。
Br J Pharmacol. 2022 Jul;179(13):3103-3118. doi: 10.1111/bph.15746. Epub 2021 Dec 12.
2
Brain mineralocorticoid receptor in health and disease: From molecular signalling to cognitive and emotional function.脑盐皮质激素受体在健康和疾病中的作用:从分子信号到认知和情绪功能。
Br J Pharmacol. 2022 Jul;179(13):3205-3219. doi: 10.1111/bph.15835. Epub 2022 Apr 7.
3
Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor.朝着盐皮质激素受体的组织选择性药理学的方法。
Br J Pharmacol. 2022 Jul;179(13):3235-3249. doi: 10.1111/bph.15719. Epub 2021 Dec 16.
4
The mineralocorticoid receptor in skin disease.皮肤疾病中的盐皮质激素受体。
Br J Pharmacol. 2022 Jul;179(13):3178-3189. doi: 10.1111/bph.15736. Epub 2021 Dec 23.
5
Mineralocorticoid receptors in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的盐皮质激素受体。
Br J Pharmacol. 2022 Jul;179(13):3165-3177. doi: 10.1111/bph.15784. Epub 2022 Feb 4.
6
Mineralocorticoid receptor in cardiovascular diseases-Clinical trials and mechanistic insights.心血管疾病中的盐皮质激素受体:临床试验与机制见解。
Br J Pharmacol. 2022 Jul;179(13):3119-3134. doi: 10.1111/bph.15708. Epub 2021 Nov 17.
7
Mineralocorticoid pathway in retinal health and diseases.视网膜健康与疾病中的盐皮质激素通路。
Br J Pharmacol. 2022 Jul;179(13):3190-3204. doi: 10.1111/bph.15770. Epub 2022 Jan 28.
8
The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.矿物质皮质激素受体在心血管疾病免疫细胞中的作用。
Br J Pharmacol. 2022 Jul;179(13):3135-3151. doi: 10.1111/bph.15782. Epub 2022 Feb 15.
9
The mineralocorticoid receptor in chronic kidney disease.慢性肾脏病中的盐皮质激素受体。
Br J Pharmacol. 2022 Jul;179(13):3152-3164. doi: 10.1111/bph.15734. Epub 2021 Dec 28.
10
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.糖皮质激素和盐皮质激素受体中激素选择性的演变。
J Steroid Biochem Mol Biol. 2013 Sep;137:57-70. doi: 10.1016/j.jsbmb.2013.07.009. Epub 2013 Jul 29.

引用本文的文献

1
Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects.盐皮质激素受体拮抗剂与射血分数保留的心力衰竭:当前认识与未来展望。
Heart Fail Rev. 2025 Jan;30(1):191-208. doi: 10.1007/s10741-024-10455-1. Epub 2024 Oct 17.
2
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia.先天性肾上腺皮质增生症的心脏代谢方面
Endocr Rev. 2025 Jan 10;46(1):80-148. doi: 10.1210/endrev/bnae026.
3
Comparative efficacy and safety of SGLT2is and ns-MRAs in patients with diabetic kidney disease: a systematic review and network meta-analysis.
SGLT2is 和 ns-MRAs 在糖尿病肾病患者中的疗效和安全性比较:系统评价和网络荟萃分析。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1429261. doi: 10.3389/fendo.2024.1429261. eCollection 2024.
4
The Interaction of Vasopressin with Hormones of the Hypothalamo-Pituitary-Adrenal Axis: The Significance for Therapeutic Strategies in Cardiovascular and Metabolic Diseases.血管升压素与下丘脑-垂体-肾上腺轴激素的相互作用:对心血管和代谢疾病治疗策略的意义。
Int J Mol Sci. 2024 Jul 5;25(13):7394. doi: 10.3390/ijms25137394.
5
Novel Evolution of Mineralocorticoid Receptor in Humans Compared to Chimpanzees, Gorillas, and Orangutans.人类与黑猩猩、大猩猩和猩猩的盐皮质激素受体的新型进化比较。
Genes (Basel). 2024 Jun 12;15(6):767. doi: 10.3390/genes15060767.
6
Mineralocorticoid Receptor Antagonism Reduces Inflammatory Pain Measures in Mice Independent of the Receptors on Sensory Neurons.醛固酮受体拮抗作用可减轻小鼠的炎性痛觉,而与感觉神经元上的受体无关。
Neuroscience. 2024 Mar 16;541:64-76. doi: 10.1016/j.neuroscience.2024.01.024. Epub 2024 Feb 1.
7
The mineralocorticoid receptor forms higher order oligomers upon DNA binding.醛固酮受体在与 DNA 结合时形成更高阶的寡聚体。
Protein Sci. 2024 Mar;33(3):e4890. doi: 10.1002/pro.4890.
8
Cardiovascular and Renal Benefit of Novel Non-steroidal Mineralocorticoid Antagonists in Patients with Diabetes.新型非甾体类盐皮质激素拮抗剂对糖尿病患者心血管和肾脏的益处
Curr Cardiol Rep. 2023 Dec;25(12):1859-1864. doi: 10.1007/s11886-023-01998-0. Epub 2023 Nov 22.
9
A narrative review of the effects of dexamethasone on traumatic brain injury in clinical and animal studies: focusing on inflammation.一项关于地塞米松在临床和动物研究中对创伤性脑损伤影响的叙述性综述:重点关注炎症。
Inflammopharmacology. 2023 Dec;31(6):2955-2971. doi: 10.1007/s10787-023-01361-3. Epub 2023 Oct 16.
10
Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?重新评估孕激素在卵巢癌中的作用:孕激素总是保护性的吗?
Endocr Rev. 2023 Nov 9;44(6):1029-1046. doi: 10.1210/endrev/bnad018.